Exelixis Stock Price Prediction

EXEL Stock  USD 33.82  0.34  1.02%   
As of now, The RSI of Exelixis' share price is at 55 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Exelixis, making its price go up or down.

Oversold Vs Overbought

55

 
Oversold
 
Overbought
The successful prediction of Exelixis' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Exelixis and does not consider all of the tangible or intangible factors available from Exelixis' fundamental data. We analyze noise-free headlines and recent hype associated with Exelixis, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Exelixis' stock price prediction:
Quarterly Earnings Growth
121.699
EPS Estimate Next Quarter
0.33
EPS Estimate Current Year
1.9525
EPS Estimate Next Year
2.0043
Wall Street Target Price
33.38
Using Exelixis hype-based prediction, you can estimate the value of Exelixis from the perspective of Exelixis response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Exelixis to buy its stock at a price that has no basis in reality. In that case, they are not buying Exelixis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Exelixis after-hype prediction price

    
  USD 33.74  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Exelixis Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Exelixis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
29.5531.9734.39
Details
Naive
Forecast
LowNextHigh
30.8733.2935.71
Details
21 Analysts
Consensus
LowTargetHigh
23.4425.7628.59
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.430.490.56
Details

Exelixis After-Hype Price Prediction Density Analysis

As far as predicting the price of Exelixis at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Exelixis or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Exelixis, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Exelixis Estimiated After-Hype Price Volatility

In the context of predicting Exelixis' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Exelixis' historical news coverage. Exelixis' after-hype downside and upside margins for the prediction period are 31.32 and 36.16, respectively. We have considered Exelixis' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
33.82
33.74
After-hype Price
36.16
Upside
Exelixis is very steady at this time. Analysis and calculation of next after-hype price of Exelixis is based on 3 months time horizon.

Exelixis Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Exelixis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Exelixis backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Exelixis, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.44 
2.42
  0.08 
  0.35 
10 Events / Month
11 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
33.82
33.74
0.24 
1,344  
Notes

Exelixis Hype Timeline

Exelixis is currently traded for 33.82. The entity has historical hype elasticity of -0.08, and average elasticity to hype of competition of 0.35. Exelixis is forecasted to decline in value after the next headline, with the price expected to drop to 33.74. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.24%, whereas the daily expected return is currently at 0.44%. The volatility of related hype on Exelixis is about 304.97%, with the expected price after the next announcement by competition of 34.17. About 89.0% of the company shares are held by institutions such as insurance companies. The book value of Exelixis was currently reported as 7.96. The company has Price/Earnings To Growth (PEG) ratio of 2.27. Exelixis had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days.
Check out Exelixis Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

Exelixis Related Hype Analysis

Having access to credible news sources related to Exelixis' direct competition is more important than ever and may enhance your ability to predict Exelixis' future price movements. Getting to know how Exelixis' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Exelixis may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TGTXTG Therapeutics 4.30 7 per month 3.29  0.13  7.43 (4.84) 24.51 
VKTXViking Therapeutics(4.81)7 per month 0.00 (0.11) 5.82 (8.05) 39.28 
MDGLMadrigal Pharmaceuticals 13.24 10 per month 2.04  0.12  5.17 (3.96) 30.27 
BTAIBioXcel Therapeutics(0.11)7 per month 0.00 (0.10) 9.62 (8.89) 29.34 
BMRNBiomarin Pharmaceutical(0.15)12 per month 0.00 (0.06) 1.77 (2.84) 8.97 
SGENSeagen Inc 0.00 0 per month 0.00 (0.11) 1.02 (0.89) 6.86 
ALNYAlnylam Pharmaceuticals(0.35)11 per month 0.00 (0.09) 2.85 (3.51) 13.26 
HALOHalozyme Therapeutics(0.1)12 per month 0.00 (0.08) 3.90 (6.75) 28.41 
XFORX4 Pharmaceuticals 0.1 9 per month 10.71  0.04  13.85 (13.51) 67.48 
PDSBPDS Biotechnology Corp(0.18)8 per month 0.00 (0.17) 8.37 (8.65) 31.83 
PTCTPTC Therapeutics(0.13)11 per month 2.31  0.08  7.02 (4.04) 23.95 
RETAReata Pharmaceuticals(0.50)3 per month 3.31  0.04  5.24 (3.51) 28.80 
ICPTIntercept Pharmaceuticals 0.66 3 per month 0.00 (0.16) 5.23 (8.32) 38.17 
KRYSKrystal Biotech 0.86 10 per month 0.00 (0.08) 3.21 (4.59) 14.97 
KODKodiak Sciences 0.14 7 per month 2.23  0.39  10.00 (4.13) 40.23 
SRPTSarepta Therapeutics 0.52 9 per month 0.00 (0.02) 3.75 (4.04) 18.21 
MRTXMirati Ther 0.00 0 per month 0.00 (0.15) 4.02 (4.07) 16.13 

Exelixis Additional Predictive Modules

Most predictive techniques to examine Exelixis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Exelixis using various technical indicators. When you analyze Exelixis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Exelixis Predictive Indicators

The successful prediction of Exelixis stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Exelixis, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Exelixis based on analysis of Exelixis hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Exelixis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Exelixis's related companies.
 2016 2021 2022 2024 (projected)
Payables Turnover1.532.182.152.29
Days Of Inventory On Hand211.05189.7987.16180.3

Story Coverage note for Exelixis

The number of cover stories for Exelixis depends on current market conditions and Exelixis' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Exelixis is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Exelixis' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Exelixis Short Properties

Exelixis' future price predictability will typically decrease when Exelixis' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Exelixis often depends not only on the future outlook of the potential Exelixis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Exelixis' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding321.5 M
Cash And Short Term Investments995.3 M
When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:
Check out Exelixis Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
121.699
Earnings Share
1.55
Revenue Per Share
7.032
Quarterly Revenue Growth
0.143
Return On Assets
0.1281
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.